NCT03192501View on ClinicalTrials.gov

iCAGES-guided Precision Therapy for Cancers in Contrast to Standard Care or IHC-guided Theray

RecruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

July 1, 2030

Study Completion Date

July 1, 2039

Conditions
Lung CancerGene AbnormalityGene Product Sequence VariationCancer
Interventions
DRUG

inhibitors, ADC drugs such as tarceva, capmatinib, padcev et al for A/C group.

Choose appropriate targeted drugs according to NGS/IHC results.

Trial Locations (1)

510260

RECRUITING

The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors
collaborator

The First Affiliated Hospital of Guangzhou Medical University

OTHER

collaborator

Sun Yat-sen University

OTHER

lead

Second Affiliated Hospital of Guangzhou Medical University

OTHER